1.
N Z Med J
; 128(1423): 63-76, 2015 Oct 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26645757
RESUMO
The management of patients with ulcerative colitis who are dependent on corticosteroid for control of symptoms, or refractory to corticosteroids or standard immunosuppressive therapy, is challenging. The development of newer medical therapies has increased the options for managing patients in this situation, but access and funding remain limited. This guideline summarises the literature regarding this situation and provides guidance as to the management of refractory colitis in the New Zealand setting.